EmulsiFlex-C3 Homogenizer

The National Institutes of Health (NIH), under the Department of Health and Human Services, intends to procure an EmulsiFlex-C3 Homogenizer with an integrated heat exchanger and heat exchange coil for the Laboratory of Molecular Biology at its Bethesda, Maryland facility. This equipment is critical for high-pressure cell disruption to facilitate efficient protein extraction and purification, supporting vital biological and disease-related research. The procurement is conducted as a sole-source, firm-fixed-price purchase order under solicitation number 75N98026Q00319, justified under FAR 6.302-1 as only one responsible source, Avestin Inc., can provide this specialized equipment. The solicitation was posted on May 5, 2026, with a response deadline of May 15, 2026, and an anticipated award date around May 20, 2026. The contract documentation includes a Notice of Intent to award the purchase and invites capability statements via email to a designated NIH contact. No competitive evaluation factors, pricing details, or formal proposal formatting instructions are provided, reflecting the sole-source nature of this acquisition. Key contract clauses, packaging, marking, and detailed inspection standards are not included in the available materials, although the government will oversee inspection and acceptance at the Bethesda location. There are no identified special contract requirements such as security clearances or organizational conflict of interest provisions, nor are payment instructions or invoicing procedures specified. Small business participation is noted as permissible but not mandatory. Overall, the acquisition focuses on securing a uniquely capable instrument to enhance NIH research operations without engaging in competitive bidding or extensive administrative clauses.